James M. Travers Sells 60,000 Shares of DocGo Inc. (NASDAQ:DCGO) Stock

DocGo Inc. (NASDAQ:DCGOGet Rating) Director James M. Travers sold 60,000 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $8.55, for a total value of $513,000.00. Following the transaction, the director now directly owns 456,028 shares of the company’s stock, valued at approximately $3,899,039.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

DocGo Stock Up 2.4 %

DCGO stock opened at $9.25 on Friday. The firm has a market cap of $948.22 million, a PE ratio of 46.25 and a beta of 0.93. DocGo Inc. has a 12-month low of $6.01 and a 12-month high of $11.41. The business has a 50 day moving average of $8.38 and a 200-day moving average of $8.22.

DocGo (NASDAQ:DCGOGet Rating) last announced its earnings results on Monday, March 13th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.06. DocGo had a net margin of 4.70% and a return on equity of 7.05%. The business had revenue of $108.79 million during the quarter, compared to analyst estimates of $104.13 million. During the same period in the previous year, the business posted $0.17 earnings per share. On average, research analysts expect that DocGo Inc. will post 0.28 earnings per share for the current year.

Institutional Trading of DocGo

Institutional investors have recently added to or reduced their stakes in the business. Altshuler Shaham Ltd bought a new stake in DocGo during the 3rd quarter valued at approximately $28,000. Federated Hermes Inc. bought a new stake in DocGo in the 3rd quarter valued at $29,000. Royal Bank of Canada lifted its stake in DocGo by 226.3% in the 1st quarter. Royal Bank of Canada now owns 3,263 shares of the company’s stock worth $30,000 after purchasing an additional 2,263 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of DocGo in the third quarter worth about $39,000. Finally, Wells Fargo & Company MN lifted its position in shares of DocGo by 320.1% in the fourth quarter. Wells Fargo & Company MN now owns 6,192 shares of the company’s stock worth $44,000 after buying an additional 4,718 shares in the last quarter. 36.88% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on DCGO shares. Needham & Company LLC reiterated a “buy” rating and issued a $14.00 target price on shares of DocGo in a research report on Friday, April 21st. Cantor Fitzgerald assumed coverage on DocGo in a research note on Thursday, April 20th. They issued an “overweight” rating and a $11.00 price objective on the stock.

About DocGo

(Get Rating)

DocGo, Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.